Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Cloning and pharmacological characterization of the dog P2X7 receptor.

Roman S, Cusdin FS, Fonfria E, Goodwin JA, Reeves J, Lappin SC, Chambers L, Walter DS, Clay WC, Michel AD.

Br J Pharmacol. 2009 Nov;158(6):1513-26. doi: 10.1111/j.1476-5381.2009.00425.x. Epub 2009 Oct 8.

2.

Mechanism of action of species-selective P2X(7) receptor antagonists.

Michel AD, Ng SW, Roman S, Clay WC, Dean DK, Walter DS.

Br J Pharmacol. 2009 Apr;156(8):1312-25. doi: 10.1111/j.1476-5381.2009.00135.x. Epub 2009 Mar 20.

3.

Identification of regions of the P2X(7) receptor that contribute to human and rat species differences in antagonist effects.

Michel AD, Clay WC, Ng SW, Roman S, Thompson K, Condreay JP, Hall M, Holbrook J, Livermore D, Senger S.

Br J Pharmacol. 2008 Nov;155(5):738-51. doi: 10.1038/bjp.2008.306. Epub 2008 Jul 28.

4.

Cloning and pharmacological characterization of the guinea pig P2X7 receptor orthologue.

Fonfria E, Clay WC, Levy DS, Goodwin JA, Roman S, Smith GD, Condreay JP, Michel AD.

Br J Pharmacol. 2008 Feb;153(3):544-56. Epub 2007 Nov 26.

5.

Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding.

Michel AD, Chambers LJ, Clay WC, Condreay JP, Walter DS, Chessell IP.

Br J Pharmacol. 2007 May;151(1):103-14. Epub 2007 Mar 5.

6.

Evaluation of cell-based assays for steroid nuclear receptors delivered by recombinant baculoviruses.

Katso RM, Parham JH, Caivano M, Clay WC, Condreay JP, Gray DW, Lindley KM, Mason SJ, Rieger J, Wakes NC, Cairns WJ, Merrihew RV.

J Biomol Screen. 2005 Oct;10(7):715-24. Epub 2005 Aug 29.

PMID:
16129777
7.

Recombinant baculoviruses used to study estrogen receptor function in human osteosarcoma cells.

Clay WC, Condreay JP, Moore LB, Weaver SL, Watson MA, Kost TA, Lorenz JJ.

Assay Drug Dev Technol. 2003 Dec;1(6):801-10.

PMID:
15090226
8.

Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology.

Jenkinson S, McCoy DC, Kerner SA, Ferris RG, Lawrence WK, Clay WC, Condreay JP, Smith CD.

J Biomol Screen. 2003 Aug;8(4):463-70.

PMID:
14567799
9.

Chromosomal integration of transduced recombinant baculovirus DNA in mammalian cells.

Merrihew RV, Clay WC, Condreay JP, Witherspoon SM, Dallas WS, Kost TA.

J Virol. 2001 Jan;75(2):903-9.

10.

Replication-associated activities of purified human papillomavirus type 11 E1 helicase.

Rocque WJ, Porter DJ, Barnes JA, Dixon EP, Lobe DC, Su JL, Willard DH, Gaillard R, Condreay JP, Clay WC, Hoffman CR, Overton LK, Pahel G, Kost TA, Phelps WC.

Protein Expr Purif. 2000 Mar;18(2):148-59.

PMID:
10686145
11.

Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE).

Milla ME, Leesnitzer MA, Moss ML, Clay WC, Carter HL, Miller AB, Su JL, Lambert MH, Willard DH, Sheeley DM, Kost TA, Burkhart W, Moyer M, Blackburn RK, Pahel GL, Mitchell JL, Hoffman CR, Becherer JD.

J Biol Chem. 1999 Oct 22;274(43):30563-70.

12.

Monitor peptide binding sites are expressed in the rat liver and small intestine.

McVey DC, Romac JM, Clay WC, Kost TA, Liddle RA, Vigna SR.

Peptides. 1999;20(4):457-64.

PMID:
10458515
13.

Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector.

Condreay JP, Witherspoon SM, Clay WC, Kost TA.

Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):127-32.

14.

Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist.

Ignar DM, Andrews JL, Witherspoon SM, Leray JD, Clay WC, Kilpatrick K, Onori J, Kost T, Emerson DL.

Clin Exp Metastasis. 1998 Jan;16(1):9-20.

PMID:
9502073
15.

Human recombinant phosphodiesterase 4B2B binds (R)-rolipram at a single site with two affinities.

Rocque WJ, Tian G, Wiseman JS, Holmes WD, Zajac-Thompson I, Willard DH, Patel IR, Wisely GB, Clay WC, Kadwell SH, Hoffman CR, Luther MA.

Biochemistry. 1997 Nov 18;36(46):14250-61.

PMID:
9369498
16.

Production of a urokinase plasminogen activator-IgG fusion protein (uPA-IgG) in the baculovirus expression system.

Kost TA, Ignar DM, Clay WC, Andrews J, Leray JD, Overton L, Hoffman CR, Kilpatrick KE, Ellis B, Emerson DL.

Gene. 1997 Apr 29;190(1):139-44.

PMID:
9185859
17.

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.

Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Becherer JD, et al.

Nature. 1997 Feb 20;385(6618):733-6. Erratum in: Nature 1997 Apr 17;386(6626):738.

PMID:
9034191
18.

NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site.

Cogswell JP, Godlevski MM, Wisely GB, Clay WC, Leesnitzer LM, Ways JP, Gray JG.

J Immunol. 1994 Jul 15;153(2):712-23.

PMID:
8021507
19.

A CRE/ATF-like site in the upstream regulatory sequence of the human interleukin 1 beta gene is necessary for induction in U937 and THP-1 monocytic cell lines.

Gray JG, Chandra G, Clay WC, Stinnett SW, Haneline SA, Lorenz JJ, Patel IR, Wisely GB, Furdon PJ, Taylor JD, et al.

Mol Cell Biol. 1993 Nov;13(11):6678-89.

20.
21.
22.

An ambulatory, intermediate term left ventricular assist device.

Poirier VL, Sherman CW, Clay WC, Graham TR, Withington PS, Marrinan MT, Lewis CT.

ASAIO Trans. 1989 Jul-Sep;35(3):452-5.

PMID:
2597504
23.

Investigations with an implantable, electrically actuated ventricular assist device.

Bernhard WF, Gernes DG, Clay WC, Schoen FJ, Burgeson R, Valeri RC, Melaragno AJ, Poirier VL.

J Thorac Cardiovasc Surg. 1984 Jul;88(1):11-21.

PMID:
6738093
24.

Development and evaluation of a long-term, implantable, electrically actuated left ventricular assist system: THI/Gould LVAS.

Norman JC, McGee MG, Fuqua JM, Igo SR, Turner SA, Sterling R, Urrutia CO, Frazier OH, Clay WC, Chambers JA.

Artif Organs. 1983 Feb;7(1):64-73.

PMID:
6838409
25.

Chronic in vivo evaluations of a long-term, implantable left ventricular assist system.

McGee MG, Igo SR, Fuqua JM, Creager GJ, Urrutia CO, Pool GE, Painvin GA, Krudewig TW, Chambers JA, Clay WC, et al.

Trans Am Soc Artif Intern Organs. 1983;29:97-102.

PMID:
6673330
26.

Development of an implantable, integrated, electrically powered ventricular assist system.

Gernes DB, Bernhard WF, Clay WC, Sherman CW, Burke D.

Trans Am Soc Artif Intern Organs. 1983;29:546-50. No abstract available.

PMID:
6673284
27.

Development and evaluation of electrically actuated abdominal left ventricular assist systems for long-term use.

Fuqua JM Jr, Igo SR, Hibbs CW, Poirier VL, Chambers JA, Clay WC, McGee MG, Turner SA, Norman JC.

J Thorac Cardiovasc Surg. 1981 May;81(5):718-26.

PMID:
7218835
28.

Control system evaluations of the THI/Gould LVAS: pump rate and stroke volume responsiveness during exercise in the unanesthetized calf.

Igo SR, Turner SA, Fuqua JM, McGee MG, Chambers JA, Clay WC, Norman JC.

Trans Am Soc Artif Intern Organs. 1981;27:454-60. No abstract available.

PMID:
7331112

Supplemental Content

Support Center